Zelquistinel
Overview[edit | edit source]
Zelquistinel is a novel pharmaceutical compound under investigation for its potential use in the treatment of major depressive disorder (MDD). It is classified as a NMDA receptor modulator, which distinguishes it from traditional antidepressants that typically target monoamine neurotransmitters.
Mechanism of Action[edit | edit source]
Zelquistinel functions as a positive allosteric modulator of the NMDA receptor, a type of glutamate receptor in the central nervous system. By enhancing the activity of these receptors, zelquistinel is thought to facilitate synaptic plasticity and neuroprotection, which may contribute to its antidepressant effects.
Development and Research[edit | edit source]
The development of zelquistinel is part of a broader effort to create rapid-acting antidepressants. Unlike traditional antidepressants, which can take weeks to exhibit effects, NMDA receptor modulators like zelquistinel may offer faster relief of depressive symptoms. Preclinical studies have shown promising results, and clinical trials are ongoing to evaluate its efficacy and safety in humans.
Potential Benefits[edit | edit source]
Zelquistinel's unique mechanism of action may offer several advantages over existing treatments for depression:
- Rapid onset of action: Potential to alleviate symptoms within hours or days.
- Reduced side effects: May have a different side effect profile compared to SSRIs and SNRIs.
- Neuroprotective properties: Could provide additional benefits in terms of cognitive function and neuroprotection.
Challenges and Considerations[edit | edit source]
While zelquistinel shows promise, there are challenges that need to be addressed:
- Long-term safety: The effects of prolonged NMDA receptor modulation are not fully understood.
- Individual variability: Response to treatment may vary among individuals, necessitating personalized approaches.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD